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ABSTRACT
CRISPR-Cas is an RNA-guided adaptive immune sys-
tem that protects bacteria and archaea from invading
nucleic acids. Type III systems (Cmr, Csm) have been
shown to cleave RNA targets in vitro and some are ca-
pable of transcription-dependent DNA targeting. The
crenarchaeon Sulfolobus solfataricus has two diver-
gent subtypes of the type III system (Sso-IIID and
a Cmr7-containing variant of Sso-IIIB). Here, we re-
port that both the Sso-IIID and Sso-IIIB complexes
cleave cognate RNA targets with a ruler mechanism
and 6 or 12 nt spacing that relates to the organiza-
tion of the Cas7 backbone. This backbone-mediated
cleavage activity thus appears universal for the type
III systems. The Sso-IIIB complex is also known to
possess a distinct ‘UA’ cleavage mode. The predom-
inant activity observed in vitro depends on the rela-
tive molar concentration of protein and target RNA.
The Sso-IIID complex can cleave plasmid DNA tar-
gets in vitro, generating linear DNA products with an
activity that is dependent on both the cyclase and HD
nuclease domains of the Cas10 subunit, suggesting
a role for both nuclease active sites in the degrada-
tion of double-stranded DNA targets.
INTRODUCTION
One mechanism used by bacteria and archaea to protect
themselves from invading nucleic acids is the adaptive im-
mune system CRISPR-Cas, comprised of CRISPR arrays
of repeat-spacer units and CRISPR-associated (Cas) genes
(reviewed in (1)). The CRISPR-Cas system acts through
three stages. First, short fragments of invading viruses and
plasmids are captured and integrated into CRISPR arrays
in a process known as acquisition or adaptation (2), gen-
erating a library of ‘non-self ’ spacer sequences. Second,
the CRISPR loci are transcribed and processed into short
CRISPR RNAs (crRNAs) (reviewed in (3)). These unit
length crRNAs are subsequently assembled with Cas pro-
teins into large ribonucleoprotein effector or surveillance
complexes. Guided by the crRNA sequence, the effector
complexes detect and degrade cognate nucleic acids (re-
viewed in (4)).
CRISPR-Cas systems have been classified into five types
(5,6). Distant phylogenetic relationships have been reported
between several proteins from type I and III systems (7), in
particular the Cas7 subunit (8). This relationship was con-
firmed by electron microscopy studies of the type III com-
plexes, which revealed a helical backbone formed by Cas7
family subunits binding to the crRNA (9–11), with a strik-
ing similarity to that observed in the type I Cascade struc-
ture (12). However, these two systems are mechanistically
distinct. Type I systems target double-stranded DNA and
recruit the Cas3 helicase:nuclease protein to unwind and de-
grade target DNA. In contrast, type III systems were orig-
inally shown to target single-stranded RNA using either a
ruler-dependent cleavage with 6 nucleotide (nt) spacing, as
observed for the type IIIB complex from Pyrococcus furio-
sus (13) or a sequence-dependent ‘UA’ cleavage mechanism
for the Cmr7-containing type IIIB complex from Sulfolobus
solfataricus (14). These activities have also been shown to
occur in vivo in two Sulfolobus species (15,16).
In contrast, the type IIIA systems have long been known
to possess a DNA targeting activity in vivo (17), but this
proved difficult to demonstrate in vitro, although the HD
nuclease domain of the large subunit (Csm1/Cas10) was
reported to possess DNA nuclease activity (18). Recently,
a ruler-dependent ‘RNA shredding’ activity was described
for the type IIIA complex from Streptococcus thermophilus
(19). This study demonstrated that the bound RNA target
was cleaved at regular 6 nt intervals along the Cas7 back-
bone of the complex, an activity dependent on a conserved
acidic residue in the Csm3 subunit (19). Subsequently, this
mechanism of RNA degradation has been observed for sev-
eral other type III systems (20–23). Most recently, the crys-
tal structure of a chimeric type IIIB complex bound to cr-
RNA and target RNA revealed regular nt flipping of cr-
RNA with a 6 nt periodicity, caused by the insertion of a
conserved beta-hairpin ‘thumb’ of the Cmr4 (Cas7) subunit
into the RNA duplex (24). The thumb includes the con-
served acidic residue important for target RNA cleavage,
suggesting that the local distortion and chemical environ-
ment at these positions is key to the periodic, backbone-
mediated target RNA cleavage observed in the type III sys-
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tems. This structural arrangement is strikingly reminiscent
of the Cas7-mediated distortion observed in the structure
of Escherichia coli Cascade bound to a crRNA:DNA het-
eroduplex (25), emphasizing the fundamental conservation
of nucleic acid binding across the type I and type III systems
(26).
In parallel with these studies, genetic analyses of a Sul-
folobus islandicus type III system suggested that the com-
plex cleaved DNA in a transcription-dependent mecha-
nism (27). This observation was confirmed by studies of the
Staphylococcus epidermidis type IIIA system by the Mar-
raffini lab, who showed that DNA targeting by the type
IIIA system is dependent on the transcription of the DNA
target––a mechanism that they proposed allows dormant
lysogenic phage DNA in the genome to escape degradation
(28). Most recently, this activity was reconstituted in vitro,
demonstrating thatDNAcleavage by theS. epidermidis type
IIIA complex was dependent on transcription of the target
DNA by RNA polymerase (29). The active site responsi-
ble for the DNA cleavage, which was observed on only one
DNA strand, was identified in the conserved cyclase do-
main of the large subunit, Csm1 (29), consistent with recent
biochemical studies of Csm1 in isolation (30).
Thus, there is an emerging consensus that type III sys-
tems have a backbone-mediated ‘RNA shredding’ activity
(although the functional relevance of this activity remains
uncertain) and some at least also possess a transcription-
dependent DNA targeting activity. The type III systems
present in S. solfataricus strain P2 are relatively unusual.
The complex previously denoted as belonging to type IIIA
is now classified as a type IIID system (6). The type IIIB
complex was reported to have a more compact, ‘crab claw’
structure and has an extra subunit, Cmr7, found in only a
few type IIIB systems (14). Here, we demonstrate that the S.
solfataricus type IIID and IIIB systems (previously known
as theCsmandCmr complexes, hereafter Sso-IIID and Sso-
IIIB) also possess a backbone-mediatedRNA shredding ac-
tivity in vitro, confirming that RNA shredding is a univer-
sal property of all type III systems. Furthermore, the Sso-
IIID complex can cleave dsDNA targets in vitro and the
Sso-IIIB system can switch between sequence-dependent
and backbone-mediated cleavage modes, depending on the
amount of RNA target available.
MATERIALS AND METHODS
Oligonucleotides for polymerase chain reaction (PCR), sub-
cloning and site directed mutagenesis
The oligonucleotides were synthesized by Integrated DNA
Technologies (IDT) and the sequences are available on re-
quest from the corresponding author.
Expression and purification of tagged Sso-IIID and Sso-IIIB
complexes from S. solfataricus
The Sso-IIID complex used in this study was tagged on the
large subunit, Csm1/Sso1428. The Sso-IIIB complex was
tagged on the subunit Sso1990. The gene encoding Sso1428
or Sso1990 was PCR amplified and cloned into pMZ1 (31),
then subcloned into expression vector pSVA9 that expresses
the relevant subunit with a C-terminal strep-His tag (32).
The expression vector carrying the gene encoding Sso1428
or Sso1990 was transformed into the S. solfataricus PH1–16
expression strain. After transformation, cells were first cul-
tivated in unselective Brock medium containing 0.1% (w/v)
tryptone and 10!g/ml uracil, and then transferred to selec-
tive media containing 0.2% (w/v) glucose and 0.1% (w/v)
NZ-amine without uracil. Once the A600 nm reached 0.6,
cells were transferred to expression media containing 0.2%
(w/v) arabinose and 0.1% (w/v) NZ-amine to induce the
expression of the tagged subunit and then collected at an
A600 nm of 0.8 - 1.0. Cells were harvested by centrifuga-
tion and disrupted by sonication (Soniprep 150, MSE) in
buffer A (20 mM HEPES pH 7.5, 250 mM NaCl, 30 mM
imidazole). The supernatant was filtered and loaded onto
a Histrap column (GE Healthcare) in buffer A. His-tagged
proteins were eluted with a linear gradient of buffer B (20
mM HEPES pH 7.5, 250 mM NaCl, 500 mM imidazole).
Fractions containing the tagged complex were pooled and
exchanged into buffer C (20 mM Tris-HCl pH 8.0, 50 mM
NaCl) then loaded onto a mono Q column (GE Health-
care) equilibrated in buffer C. Bound proteins were eluted
with a linear gradient of buffer D (20 mMTris-HCl pH 8.0,
1 M NaCl). Fractions containing the tagged complex were
pooled, concentrated and loaded onto a Sephacryl 300 size
exclusion column (GE Healthcare) equilibrated in buffer E
(20 mMTris-HCl pH 8.0, 250 mMNaCl). The purified pro-
teins were concentrated and stored at 4◦C.
To generate a variant Sso-IIIB complex with a mu-
tated HD domain, the gene encoding the large subunit,
Cmr2/Sso1991, was PCR amplified and cloned into a mod-
ified pMZ1 containing an N-terminal strep-His tag, result-
ing in pMZ1-Nhis-sso1991. Mutations of residues D181
and H182 to alanine were carried out by PCR mutagenesis
using Phusion DNA polymerase (ThermoFisher Scientific)
and pMZ1-Nhis-sso1991 as the template. Variants of the
Sso-IIID complex with mutations targeted to the HD nu-
clease (H187A, D188A) and cyclase (D629A, D630A) do-
mains were constructed in a similarmanner. The procedures
for subcloning, expression and purification of these variant
proteins were as described above.
Cloning, expression and purification of Sso-IIID subunits
The gene encoding each subunit except sso1428 was am-
plified by PCR and cloned into an expression vector with
an N-terminal 6x His-tag. The sso1424 gene was cloned
into the pEHisTev vector (33). The sso1425, sso1426,
sso1427, sso1430, sso1431 and sso1432 genes were cloned
into pDEST14 vector individually using the gateway re-
combination cloning (34). The constructs were expressed
in C43 (DE3) E. coli grown in LB medium supplemented
with appropriate antibiotics to anA600nm of 0.6–0.8 at 37◦C.
Expression was induced by the addition of 0.4 mM IPTG
and the cells were harvested after overnight incubation at
25◦C. The cell pellets were resuspended in buffer F (50 mM
Tris.HCl pH 7.5, 500 mM NaCl, 10 mM imidazole, 10%
glycerol) and lysed by sonication. The lysate was clarified
by centrifugation and filtered prior to loading onto a His-
trap column (GE Healthcare) equilibrated in buffer G (50
mM Tris.HCl pH 7.5, 500 mM NaCl, 30 mM imidazole).
The His-tagged proteins were eluted with a linear gradient
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of buffer H (50 mM Tris.HCl pH 7.5, 500 mM NaCl, 500
mM imidazole). Fractions containing the His-tagged pro-
tein were pooled and treated with TEV protease overnight
at room temperature for cleavage of the his-tag. The cleaved
protein was passed through a Histrap column in buffer G
and collected in the flow through then further purified by
size exclusion on a Superdex S200 column (GEHealthcare)
equilibrated in buffer I (20 mM Tris.HCl pH 7.5, 250 mM
NaCl). Fractions containing the proteins were concentrated
and stored at −20◦C.
The cell pellets for Sso1427 and Sso1431 were resus-
pended in buffer G containing 8 M urea and incubated
overnight at room temperature. Samples were subject to
sonication and ultracentrifugation at 40 000 rpm for 30 min
prior to nickel affinity chromatography in buffer G contain-
ing 8 M urea. His-tagged proteins were eluted with a linear
gradient of buffer H containing 8 M urea. Fractions con-
taining the His-tagged proteins were stored at 4◦C.
The sso1428 gene was amplified and cloned into pMZ1
and then subcloned into pSVA9 and expressed from S. sol-
fataricus as described above. The isolated Sso1428 subunit
was purified using metal affinity, ion exchange, and size ex-
clusion chromatography as for the intact complex (9). Frac-
tions containing Sso1428 were concentrated and stored at
4◦C.
Purification and end-labelling of RNA oligonucleotides
RNA oligonucleotide substrates were supplied by IDT and
purified and end labelled as described previously (14).
Sso-IIID RNA cleavage assays
Purified Sso-IIID complex and 5′-32P end-labelled synthetic
target RNA oligonucleotides were mixed in reaction buffer
1 (20 mM MES pH 6.0, 100 mM NaCl, 0.1 mg/ml BSA,
2 mM MgCl2) and incubated at 75◦C for 20 min. The re-
action was stopped by adding 1 !l of 20 mg/ml Proteinase
K (Thermo scientific) and was further incubated at 37◦C
for 30 min. Then the reaction was phenol-chloroform (Am-
bion) extracted as described previously (35). Samples from
the upper aqueous phase were mixed with formamide dye
and heated at 95◦C for 5 min before loading onto 20% poly-
acrylamide, 8Murea, 1 x TBE gels. The gels were visualized
by phosphor imaging. 5′ end-labelled RNA size standards
(DecadeMarkers, Ambion)were used to determine the sizes
of the observed products.
Sso-IIIB RNA cleavage assays
Purified Sso-IIIB complex and unlabelled crRNA were
mixed in reaction buffer 2 (20 mM MES pH 6.0, 100 mM
potassium glutamate, 10 mM DTT, 10 mM MnCl2) and
pre-incubated at 75◦C for 10min prior to the addition of 32P
5′ end-labelled synthetic target RNA to the reaction mix.
The reaction was further incubated at 75◦C for 10 min and
processed as described above.
Reconstitution of the Sso-IIID complex in vitro
Sso1424, Sso1425, Sso1426, Sso1427, Sso1428, Sso1430,
Sso1431, Sso1432 and crRNA were mixed at a ratio of
3:1:4:1:1:1:1:1:1 in reaction buffer 1 and incubated at 45◦C
for 30 min prior to the addition of 4 nM radiolabelled tar-
get RNA. The reaction was further incubated at 75◦C for
60 min then processed as described above.
Sso-IIID plasmid cleavage assays
The pT6 plasmid (36) was used as the backbone for plas-
mid cleavage assays. A synthetic DNA fragment (gBlock,
IDT) designed to incorporate sequences corresponding to
three of the most abundant crRNA sequences identified in
the Sso-IIID complex (corresponding to spacers A26 and
B2) (9) and Sso-IIIB complex (spacer D63) (14) was sub-
cloned into the BamHI site of the plasmid and the resultant
plasmid, pSpacer, was checked by DNA sequencing. The
sequence of the gBlock is presented in the supplementary
data section. Purified wild type and mutant Sso-IIID com-
plexes and plasmid DNA with or without the spacer insert
were mixed in reaction buffer 3 (10 mMTris pH 8.0, 50 mM
KCl, 2 mMMgCl2) and incubated at 40◦C for 20 min. The
reactionwas stopped by adding 1!l of 20mg/ml Proteinase
K (Thermo scientific) and was further incubated at 37◦C
for 30 min. Then the reaction was phenol-chloroform (Am-
bion) extracted as described previously (32). Samples from
the upper aqueous phase were mixed with formamide dye
and resolved on 0.8% agarose gels. GeneRuler 1kb DNA
ladder (Life Technologies) was used as a reference marker.
Band intensities were quantified using ImageJ (37). Note
that as EtBr may not bind supercoiled and relaxed DNA
with equivalent binding densities, the absolute fraction of
DNA cleaved is subject to some uncertainty. This does not
affect the comparative analysis of wild-type and variant
proteins.
RESULTS
Sso-IIID cleaves target RNA with 6 or 12 nt spacing
The type IIIA complexes from Streptococcus thermophilus,
S. epidermidis and Thermus thermophilus cleave target
RNAs at regular 6 nt intervals that correspond to the spac-
ing of the Cas7 backbone subunits (19,21,29). To test the
Sso-IIID complex for this activity we incubated the com-
plex with a labelled target RNA, A26, which has sequence
complementary to one of the most abundant crRNAs pre-
viously identified after extraction from the Sso-IIID com-
plex, comprising ≈5% of the total crRNA present (9). We
observed three major cleavage products with a 12 or 6 nt
spacing (Figure 1). Addition of further crRNAA26 reduced
the activity, suggesting that the complex may not incorpo-
rate this crRNA productively in vitro. Deletion of 5 nt from
the 5′ end of the target RNA (A26S) yielded the same 12–6
cleavage pattern with the fragments now 5 nt shorter, sug-
gesting that cleavage is directed by a ruler mechanism from
the 5′ end of the crRNA (Figure 1A), in commonwith other
type III enzymes (19,23). The assay was repeated using a
different target RNA, B2, which matches another abun-
dant crRNA identified in the Sso-IIID complex (9). Again,
a 12–6 nt spacing was observed and once again the addi-
tion of further cognate crRNA diminished the extent of tar-
get cleavage (Figure 1A). We proceeded to test Sso-IIID for
backbone-mediated cleavage using a target RNA, A1, that
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Figure 1. Sso-IIID cleaves target RNA with 6 or 12 nt spacing. 5′-32P end-labelled target RNA (4 nM) was incubated with purified endogenous Sso-
IIID complex (500 nM) in the absence or presence of corresponding crRNA (100 nM) in reaction buffer at 75◦C for 10 min, followed by denaturing gel
electrophoresis and phosphorimaging. (A) Cleavage reactions with target RNA A26, A26S (a 5 nt 5′ truncation of A26) and B2. The three lanes for each
target comprise target RNA alone, target RNA plus Sso-IIID, and target, Sso-IIID plus additional 100 nM crRNA complementary to the target. Major
cleavage sites are labelled 1–3. (B) Sequences of the guide and target RNAs used in A. Arrows indicate the locations of the cleavage products 1–3. The 8 nt
5′-handle derived from the CRISPR repeat is shown in bold. (C) Cleavage reactions with target RNA A1, a sequence that is not represented in the crRNA
content of purified Sso-IIID. The three lanes comprise target RNA alone, target RNA plus Sso-IIID, and target, Sso-IIID plus additional 100 nM crRNA
complementary to the target. (D) Time course of cleavage of the A26 target RNA by Sso-IIID. The right hand lanes are for the standard reaction with 4
nM target. On the left, unlabelled target RNA to a final concentration of 10 !Mwas added prior to initiation of the assay. Other lanes: M––RNA ladder;
C––Control lane with no added Sso-IIID.
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is not present in the purified complex (9). No cleavage was
observed, regardless of whether crRNA complementary to
A1 was provided in the assay (Figure 1C).
Initial assays were performed in the presence of 2 mM
Mg2+. Although no activity was detected in the presence
of EDTA, a broad range of divalent metal ions supported
backbone RNA cleavage by Sso-IIID, including Mg2+,
Mn2+, Ca2+, Ni2+, Co2+ and Zn2+ (Supplementary Fig-
ure S1B). A similar broad specificity was observed for the
S. thermophilus IIIA complex (19). To determine the 3′
end structure of the cleaved RNA species, we incubated
the cleavage products with E. coli Polymerase A, which
can extend RNA from a 3′-hydroxyl group. The cleavage
products remained unchanged whereas the target RNA
A26 was polyadenylated as expected (Supplementary Fig-
ure S1A). This is consistent with the presence of a 5′ hy-
droxyl group and a 2′,3′-cyclic phosphate moiety at the ends
of the cleaved RNA products, as observed for other type III
systems (13).
A time course of cleavage of the A26 target, performed
under single turnover conditions where the Sso-IIID com-
plex was present in molar excess (500 nM, of which 5% or
25 nM is loaded with crA26) over the substrate (4 nM),
demonstrated very rapid cleavage of the target at sites 1–3
with≈50% of substrate cleaved within the first 2 min. There
was little evidence for interconversion between products, al-
though the site 3 product built up more slowly over the
course of the reaction, suggesting this site may be cleaved
less rapidly than the others (Figure 1D). However, when a
large excess (10 !M) of unlabelled target RNA A26 was
added to the reaction, no substrate turnover was observed,
even after 40 min. These observations suggest that back-
bone cleavage by Sso-IIID may be a single-turnover pro-
cess, with product generation limited by the concentration
of active enzyme present.
Together, these data show that the Sso-IIID complex
shares the backbone-mediated RNA cleavage activity ob-
served for several other type III systems, but with an un-
usual spacing that suggests one cleavage site is missed,
which is explored further below. The Sso-IIID system is
not ‘programmable’ with crRNA added in trans, suggesting
that crRNA co-purifying with the complex is tightly bound
and cannot be exchanged in vitro. Furthermore, this activity
seems to be limited to a single-turnover, at least in vitro.
Reconstitution of the Sso-IIID complex from individually ex-
pressed subunits
Each subunit of Sso-IIID was cloned and expressed indi-
vidually, allowing reconstitution in recombinant form with
a defined crRNA. The large subunit (Csm1, Sso1428) was
expressed in S. solfataricus with a C-terminal polyhisti-
dine tag, as described previously (9). Isolated Csm1 could
be purified by metal affinity chromatography and sepa-
rated fromCsm1 in the Sso-IIID complex during size exclu-
sion chromatography (Supplementary Figure S2). All of the
other subunits were expressed in E. coli with cleavable N-
terminal polyhistidine tags. Subunits Sso1424, 1425, 1426,
1430 and 1432 were obtained in soluble form and purified
by metal affinity chromatography and size exclusion. Sub-
units Sso1427 and 1431 were insoluble after expression in
Figure 2. The Sso-IIID complex can be reconstituted in active form in
vitro. 5′-32P end-labelled target RNA A1 (4 nM) was incubated with puri-
fied native Sso-IIID complex (500 nM) or recombinant, reconstituted Sso-
IIID (rSso-IIID) in reaction buffer for 60 min at 75◦C, followed by dena-
turing gel electrophoresis and phosphorimaging. Native Sso-IIID lacks cr-
RNAA1 and thus does not cleave this target. Sso-IIID reconstituted from
all the individual subunits (full complex) in the presence of crRNA A1
cleaves the A1 target RNA giving four products (1–4) with 12–6–6 spacing.
Reconstitution experiments where one subunit was omitted (as indicated
in the figure) showed varying levels of activity, with individual Cas7-like
backbone subunits not essential for activity. Other lanes: M––RNA lad-
der; C––Control lane with no added Sso-IIID.
E. coli. These proteins were purified by metal affinity chro-
matography in the presence of 8 M urea (Supplementary
Figure S2). We reconstituted the Sso-IIID complex by mix-
ing the individual subunits in the presence of a defined cr-
RNA, as described in the methods. The reconstituted com-
plex was purified by size exclusion chromatography, with
the intact complexmigrating as a peak corresponding to the
retention time of the native complex, while sub-complexes
and individual subunits eluted later (Supplementary Figure
S2). Although inefficient in terms of yield, this approach
provided sufficient active reconstituted complex for bio-
chemical studies.
The Sso-IIID complex reconstituted with crRNA corre-
sponding to the A1 spacer, which is not naturally present,
catalysed cleavage of target RNA A1 with the same 12–6
nt spacing seen for the native complex (Figure 2). A fur-
ther product (site 4) was observed, with a 6 nt spacing from
site 3, suggesting that cleavage can occur at four different
sites in the backbone. To investigate the subunit require-
ments of the complex, we reconstituted Sso-IIID with in-
dividual subunits omitted, one at a time. For these experi-
ments, the reconstituted complex was not subjected to gel
filtration. Reconstitutions that omitted the large subunit
(Csm1/Sso1428), Sso1430, Sso1431 or Sso1432 all resulted
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in no detectable activity, suggesting that either complexes
are not formed or are inactive when these subunits are
absent. Sso1428 (Csm1/Cas10) and Sso1431 (Csm4/Cas5-
like) form a close interaction at the base for all type III
complexes (24,38,39). Native mass spectrometry places the
Sso1430 subunit in contact with these two basal subunits in
Sso-IIID (9), while Sso1432 is predicted to cap the Cas7-like
backbone (9). When the small subunit (Cmr2/Sso1424) or
the Cas7-like subunits Sso1425, or Sso1426 were missing,
the cleavage activity was weakened but not eliminated, sug-
gesting that these subunits play an important but not essen-
tial role. Omission of the Cas7-like subunit Sso1427 resulted
in cleavage activity comparable to the full complex (Figure
2). For all these reconstituted complexes the cleavage pat-
tern held the 12–6–6 pattern. These data suggest Sso-IIID
has the potential to form a complex capable of backbone-
mediated cleavage when one of the Cas7-like backbone sub-
units is absent, either by substituting the missing subunit
with a paralogous one, or by forming sub-complexes that
retain activity.
Dual modes of RNA cleavage by the Sso-IIIB Cmr7-
containing complex
The type IIIB complexes from P. furiosus and T. ther-
mophilius have been demonstrated to cleave the target RNA
with a regular 6 nt spacing pattern (11,40). In contrast with
these studies, we previously reported that the Sso-IIIB com-
plex, which includes the uniqueCmr7 subunit, cleaves target
RNA selectively at UA sites, rather than using a 6-nt ruler-
based mechanism (14). One difference between our original
report and the work of other labs was that we had used a
large excess of target RNA over enzyme in our assays. To
investigate this further, we carried out the RNA cleavage
reaction with 500 nM Sso-IIIB and a fixed concentration of
radioactively labelled target RNA (4 nM), and varied the
total target RNA concentration by adding unlabelled tar-
get RNA, resulting in a final substrate range from 4 to 1000
nM (Figure 3). Consistent with our previous report, Sso-
IIIB cleaved target RNA at UA sites when target RNA was
present in excess of the enzyme (Figure 3A, right hand side).
As cold target RNA was reduced below the concentration
of Sso-IIIB, the pattern changed to the canonical backbone-
mediated cleavage with 6 nt spacing observed for other type
III effector complexes. Both cleavage patterns could be de-
tected simultaneously at intermediate ratios.
To examine the possibility that the HD nuclease domain
of the Sso-IIIB complex, which is conserved in all type III
systems, played a role in the UA cleavage mode, we con-
structed a variant complexwhere the conserved ‘DH’ dipep-
tide in the HD domain was changed to an ‘AA’ motif. This
variant was expressed in S. solfataricus and purified and as-
sayed as for the wild-type protein (Figure 3B). The complex
gave robust backbone-mediated cleavage of the A1 target
RNA, as expected. The UA cleavage mode was still appar-
ent, suggesting that theHDnuclease domain is not essential
for this activity. We were unable to create variants in sub-
units such as Cmr4 or the unique Cmr7 subunit, as these are
present in multi-copy in the complex and our experimental
system does not allow deletion of the wild-type genes in S.
solfataricus, with the result that complexes would contain
mixtures of wild-type and variant subunits.
To further characterize the dual cleavage modes, we in-
vestigated the rate of substrate cleavage under the extreme
conditions that result in only one cleavage mode (Figure 4).
Under conditions of high enzyme excess, where only a sin-
gle turnover is possible, backbone cleavage occurred very
quickly, with ≈70% of the target RNA cleaved by the first
time point at 1 min. There was little further conversion over
the following 20 min reaction time course. These properties
are consistent with those of Sso-IIID under similar con-
ditions (Figure 1). To elicit the UA cleavage mode, the re-
action was carried out under conditions of high substrate
excess by adding unlabelled target RNA. Target RNA was
cleaved in multiple turnover conditions as observed previ-
ously (14), with around 50% cut over the 20 min reaction.
Both experimentswere carried out in triplicate and gels were
quantified by phosphorimaging. Figure 4B shows a plot of
the amount of target RNA substrate cleaved per nmole of
protein versus time for the two conditions. It is apparent
that the backbone-mediated cleavage occurs in rapid, single
turnover mode whilst UA cleavage displays initially slower
kinetics that nonetheless result in considerably higher levels
of substrate turnover over the course of the 20 min reaction
time.
DNA cleavage by the Sso-IIID complex
The activity of Sso-IIID wild type protein and three vari-
ants with amino acid replacements targeted to the HD do-
main, cyclase domain or both were tested for the ability to
cleave plasmid DNA (Figure 5). We constructed a plasmid
(pSpacer) containing sequences matching those of abun-
dant crRNAs present in the Sso-IIID and –IIIB complexes.
Supercoiled pSpacer plasmid DNA was cleaved by the wild
type protein to generate nicked and linear DNA products
(Figure 5A). This activity did not depend on the presence
of a cognate target DNA sequence within the plasmid, as
the parental plasmidwas cleaved similarly (not shown). This
suggests that the activity is unregulated compared to that
expected in vivo. Single-strand nicking occurs first, with the
generation of increasing quantities of linearDNAover time,
suggesting that nicked products are further converted into
linear ones by a second strand cleavage activity.
To investigate this further we compared the activities of
variants with targeted changes in the HD and cyclase ac-
tive sites, quantifying the proportions of supercoiled, nicked
and linearDNAas a function of protein:DNA ratio in repli-
cate experiments. The HD variant showed a modest but
discernible defect in processing of supercoiled DNA com-
pared to thewild type complex, with a small reduction in the
amounts of nicked products generated (Figure 5B). The cy-
clase variant gave a stronger defect, with significantly more
uncleaved plasmid apparent at the highest protein concen-
trations. The double variant yielded the most profound de-
fect, with a significant proportion of the DNA uncleaved
at the highest protein concentrations and strongly reduced
generation of nicked or linear products, even when com-
pared to the cyclase variant (Figure 5D, G). These data sug-
gest that both the HD and cyclase domains play a role in
DNA cleavage in Sso-IIID. It should be noted that, partic-
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Figure 3. Dual modes of RNA cleavage by the Sso-IIIB complex. (A) 5′-32P end-labelled target RNA A1 (4 nM) was incubated with purified endogenous
Sso-IIIB complex (500 nM) and crRNA A1 (100 nM) in reaction buffer, together with a varied concentration of unlabelled A1 target RNA (0–1000
nM). Reactions were incubated at 75◦C for 20 min, followed by denaturing gel electrophoresis and phosphorimaging. Backbone-mediated cleavage with
a 6–6–6 spacing pattern predominated where target concentration was low, but as total substrate concentration increased the cleavage mode switched to
the UA cleavage observed previously. Major cleavage sites are labelled 1–4 in black for backbone cleavage and 1–6 in grey for UA cleavage. Other lanes:
M––RNA ladder; C––A1 RNA incubated in absence of Sso-IIIB. (B) Backbone and UA cleavage modes for an Sso-IIIB complex with a variant HD
nuclease domain (D181A/H182A) in the large (Cmr2) subunit. The HD variant retained strong backbone-mediated cleavage and significant UA cleavage
activity. (C) Sequences of the guide and target A1 RNAs used in the above assay. Arrows indicate the locations of the cleavage products, labelled 1–4 in
black for backbone cleavage and 1–6 in grey for UA cleavage.
ularly for high protein:DNA concentrations, this assay may
not necessarily discriminate between the independent nick-
ing of both strands due to two distinct Sso-IIID complexes
and the coordinate nicking of both strands by the two ac-
tive sites of a single complex. This may explain why the sin-
gle HD and cyclase variants can still generate some linear
DNA.
DISCUSSION
Backbone-mediated RNA cleavage by Sso-IIID and IIIB
The observation that the Sso-IIID and IIIB-Cmr7 com-
plexes are both capable of target RNA cleavage with a
backbone-mediated 5′ ruler mechanism means that all type
III systems tested in vitro, including these two divergent ex-
amples, possess this type of activity. Although the early EM
studies of Sso-IIIB reported a ‘crab claw’ structure (14), the
biochemical data presented here support the presence of a
canonical Cas7 backbone found in all Type I and Type III
complexes. For Sso-IIIB, the four RNA cleavage sites prob-
ably correspond to the positions of the Cmr4 (Sso1987) sub-
units that make up the backbone of many type IIIB com-
plexes (22). As previously reported (19) the Sso1987 subunit
has a conserved aspartate residue (D34) equivalent to D33
in the S. thermophilus type IIIA and D26 in the P. furio-
sus IIIB systems, both of which are essential for backbone
cleavage activity (19,22). For technical reasons, we could
not generate a variant form of Sso-IIIB uniformly mutated
at this position, as gene knockouts are problematic in S. sol-
fataricus.
For the Sso-IIID effector the situation is more complex.
Figure 6 shows a schematic representation of a generic type
III complex, with details for Sso-IIID shown below. The
12–6–6 nt spacing observed for three different target RNA
species suggests that one specific position in the backbone
does not support RNA cleavage. Sso-IIID has two closely
related Cas7-like subunits, Sso1425 and Sso1426, which are
thought to be present at a stoichiometry of 1 and 4, re-
spectively (9). A simple explanation for the missed cleavage
site would therefore be that the single Sso1425 subunit does
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Figure 4. The two RNA cleavage modes of the Sso-IIIB complex possess distinct catalytic rates. (A) Time course reactions of backbone cleavage (left)
and UA cleavage (right). Conditions were 40 nM Sso-IIIB complex with target RNA A1 at 2 nM (left), or 800 nM Sso-IIIB complex with total target
RNA A1 at 500 nM (right). In both cases crRNA A1 was added to 100 nM final concentration. (B) Quantification of the extent of product formation for
the two cleavage modes. The total nmoles of product formed per nmoles of protein is plotted against reaction time. Data points are the mean of triplicate
experiments and standard errors are shown.
not support target RNA cleavage. However, reconstituted
Sso-IIID complexes lacking either Sso1425 or Sso1426 both
support target RNA cleavage with the same 12–6–6 spacing
as the native protein (Figure 2). This suggests that consid-
erable plasticity in the backbone composition of Sso-IIID
is possible, and also rules out the simple explanation of one
inactive subunit for the missed cleavage site. An alternative
explanation is that the crRNA:target RNA duplex adopts a
different conformation at the position corresponding to the
missed site, which is at position 2 in the backbone (Figure 6).
This would explain the conservation of the 12–6–6 spacing
with different target RNAs and different subunit composi-
tions. Given that the Sso-IIID complex has more distinct
subunits than any other type III system (eight, as opposed
to seven in Sso-IIIB and six in most other type III com-
plexes), it is perhaps not surprising that there may be sub-
tle differences in RNA binding. Indeed, the Sso1426 sub-
unit lacks the highly conserved ‘D33’ residue identified as
responsible for backbone- mediated cleavage in the S. ther-
mophilus type IIIA complex (19).
One possibility is that backbone-mediated RNA cleav-
age, which has largely been detected in vitro and which pre-
dominates under conditions of enzyme excess, may not be
a relevant activity in vivo. In support of this, the abolition
of backbone-mediated RNA cleavage in the S. epidermidis
type IIIA system did not significantly affect plasmid immu-
nity in vivo, whilst abrogation of DNA targeting abolished
immunity (29). Backbone-mediated RNA cleavage by the
S. thermophilus type IIIA system has been shown to pro-
vide resistance against infection by the ssRNA phage MS2
in vivo (19), but it is open to question whether this phage is
a relevant target for CRISPR systems as it is unclear how
protospacers could be captured from such a virus.
Sulfolobus islandicus REY15A, encodes two type III sys-
tems. One resembles the Sso-IIIB Cmr7 complex and does
not appear to target DNA in vivo. The other is a more
canonical type IIIB system and has been demonstrated to
possess both RNA and transcription-dependent DNA tar-
geting that provides immunity against phage. The activities
of these two complexes have been investigated in vivo. Both
could target mRNA when programmed with a cognate cr-
RNA sequence. The complex without Cmr7 was shown to
cleave RNA with a 6 nt ruler mechanism, whilst the com-
plex with Cmr7 cleaved at UA sites, and the latter complex
provided more efficient RNA targeting in vivo (16). These
data suggest that the UA cleavage mechanism of Sso-IIIB
and related complexes, which predominates in vitro when
RNA targets are present in excess, may be the dominant ac-
tivity in vivo. Unfortunately, the active site responsible for
UA cleavage remains to be determined.Mutation of theHD
nuclease active site generated a variant protein that retained
UA cleavage activity (Figure 3), whilst backbone-mediated
cleavage activity was unaffected. The Cmr7 subunit is an
attractive candidate for a catalytic role in UA cleavage. Un-
fortunately Cmr7 is present at a high stoichiometry in the
Sso-IIIB complex (14) and we are unable to express and pu-
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Figure 5. DNA cleavage by Sso-IIID is dependent on the HD and cyclase domains of the large subunit (Sso1428). Comparison of DNA cleavage activity
between wild type (A) and three variant (B-D) Sso-IIID complexes. (A) The supercoiled DNA plasmid pSpacer (SC-bottom band) is nicked (N-top band)
and linearized (L-middle band) by the wild type Sso-IIID complex, with no apparent supercoiled plasmid remaining at a 50:1 protein:plasmid ratio after
a 20 min incubation. (B–D) The efficiency of nicking and linearization is slightly reduced in the HD variant (B), more significantly reduced in the cyclase
variant (C), and severely impaired in the HD:cyclase double variant (D). (E–G) Reduction in cleavage activity for the three variants was quantified. Bars
represent the mean band intensity for each plasmid species (where SC+L+N= 100) from triplicate experiments, and error is displayed as standard deviation
(SD). Differences between the wild type and each variant Sso-IIID were determined using a T-test (one-tailed, unpaired), and significance is denoted by:
p< = 0.001. M- DNA marker (GeneRuler 1kb).
Figure 6. Schematic representation of the subunit organisation and target nucleic acid cleavage patterns for type III complexes. (A) Organisation of a
generic type III complex. The Cas10-Cas5 sub-complex defines the ‘foot’ of the structure and binds the 5′ end of the crRNA. The Cas10 subunit has two
nuclease active sites: HD nuclease (HD) and cyclase (cycl). The backbone is made up of a variable number of Cas7 and small subunits, whilst the ‘head’
has one or two subunits (green), which are not always essential. The crRNA is shown in black and target RNA in red. (B) The Sso-IIID complex has
a five-subunit backbone composed of four copies of Sso1426 and one of Sso1425. Cleavage of the target RNA (red arrows) is observed with a 12–6–6
spacing, consistent with cutting at sites 1, 3, 4 and 5. For clarity, subunits whose role and placement are unclear are omitted from this diagram. Target
DNA (magenta) may be cleaved by the HD and cyclase nuclease sites of the Csm1 subunit on separate strands (orange arrows).
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rify Sso-IIIB variants lacking wild-type copies of the Cmr7
subunit as knockouts are technically very difficult in theSul-
folobus strain used for these experiments.
DNA targeting activities of type III complexes
A variety of nuclease activities have been ascribed to type
III effector complexes (Figure 6). In addition to a presum-
ably universal backbone-mediated RNA cleavage mecha-
nism, distinct nuclease activities have been ascribed to the
large subunit of type III systems. The Thermococcus on-
nurineus Cas10 subunit acts as a metal dependent nucle-
ase in vitro with both circular and linear ssDNA substrates
and the activity appears to be located in the HD domain
(18). In contrast theDNAnuclease activity ofS. epidermidis
Cas10 in vitro was located in the cyclase domain (41), in
keeping with recent studies showing cyclase-mediated cleav-
age of DNA during transcription (29). Here we have shown
that the intact Sso-IIID complex also cleaves plasmid DNA
in vitro, albeit in a sequence-independent manner that may
represent a deregulated aspect of its activity. It appears that
the cyclase domain is more important for plasmid nicking
than the HD domain, however the most striking observa-
tion is that both the cyclase and HD domain active sites
are required for efficient conversion of supercoiled DNA
into linear form. This raises the prospect that these two nu-
clease domains in the Cas10 subunit each cut one strand
of target DNA duplexes during interference in vivo (Fig-
ure 6). This would be analogous to the situation in Cas9,
where there are two nuclease active sites, targeting opposing
strands (42). The hypothesis that both the HD and cyclase
domains, which are conserved and function as nucleases un-
der certain circumstances, collaborate to cleave target DNA
duplexes in vivo, is an attractive one. However, this awaits
definitive evidence. Clearly, there is still much to learn about
the activities and functions of the type III CRISPR effector
complexes.
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